Originally published March 2.

By Turna Ray

Life insurance providers in the US may not be using genetic information to make underwriting decisions right now, but the lobbying efforts of a Maryland-based interest group to limit legal restrictions in this area suggest that the industry's unofficial moratorium on the use of genetic information may eventually come to an end.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.